IGF1 and cancer: Thus, insulin can directly stimulate tumor growth, but numerous effects of its mitogenic and antiapoptotic action are driven by the IGF-I system, as observed in patients with high levels of circulating IGF-I with increased risk of developing several types of cancers, including prostate and breast [3,11].